Editor | Curator

136 POSTS 0 COMMENTS

Mystery Solved. Threshold Bioscience’s Neuroblo-Ibogaine!

$400 Million Man Tries Psychedelic Toads.

Compass Pathways (CMPS) Gets a Beat Down. Adding to 2025 Watch...

Interview: MAPS Founder Rick Doblin and Clearmind Medicine (CMND) CEO, Adi...

1000 Days Without Alcohol: Here’s What Happened

Startup Ketamine Clinic ‘Being Health’ Raises $5.4 Million

Non-Hallucinogenic Psychedelics or Short Term vs Long Term Acting Psychedelics, Which...

Journey Medical’s Growing Army of 1,000 Ketamine Therapists, are Available 24-7....

Guide to Miami Hedge Fund Week 2024

Helping Ketamine Clinics Succeed. Beyond Marketing.

123...14Page 1 of 14
©